Pharming Group
$13.189876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$13.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.05 (+0.39%) As of 4:27 PM UTC today
Why Robinhood?
You can buy or sell Pharming Group and other stocks, options, and ETFs commission-free!
About PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares, also called Pharming Group, is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands. The listed name for PHAR is Pharming Group N.V. ADS, each representing 10 ordinary shares.
CEO
Sijmen de Vries
Employees
—
Headquarters
Leiden, Zuid-Holland
Founded
1988
Market Cap
842.11M
Price-Earnings Ratio
20.73
Dividend Yield
—
Average Volume
8.43K
High Today
$13.26
Low Today
$13.11
Open Price
$13.25
Volume
35.49K
52 Week High
$21.99
52 Week Low
$12.68
Analyst Ratings
83%
of 6 ratings
Buy
83%
Hold
0%
Sell
17%
PHAR Earnings
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, Pre-Market